Based on the consistent expression of total Smad2 and Smad3, levels of TGF-β1 and phosphorylated Smad2 and Smad3 were upregulated in the liver fibrosis model, but decreased in the drug group, and the differences were statistically significant. This evidence concerns the gene SMAD3 and Hepatic fibrosis.